Attention deficit/hyperactivity disorder (ADHD) is a common psychiatric disorder. Using  American Psychiatric Association (2013). Diagnostic and Statistical Manual of Mental Disorders (5th edition). Describe the DSm-5  criteria for ADHD diagnosis. – What is the neurobiological and the etiology of ADHD? –  Your patient is taking Atomoxetine 40mg PO daily in the morning for ADHD. Atomoxetine is a nonstimulant drug used in the treatment of ADHD, how it work, what are the side effects and consideration using this treatment?

ADHD, or attention deficit/hyperactivity disorder, is a prevalent psychiatric disorder characterized by symptoms of inattention, hyperactivity, and impulsivity. The Diagnostic and Statistical Manual of Mental Disorders (DSM-5), published by the American Psychiatric Association in 2013, provides standardized criteria for the diagnosis of ADHD.

The DSM-5 outlines three subtypes of ADHD: predominantly inattentive presentation, predominantly hyperactive/impulsive presentation, and combined presentation. To meet the criteria for ADHD diagnosis, an individual must exhibit persistent symptoms that cause impairment in at least two different settings (e.g., home, school, work) and have an onset of symptoms before the age of 12. Moreover, the symptoms must be present for at least six months and inconsistent with developmental level.

The criteria for the predominantly inattentive presentation of ADHD include six or more symptoms of inattention, such as failure to pay close attention to details, difficulty sustaining attention, and difficulty organizing tasks and activities. Additionally, the symptoms must interfere with the individual’s functioning or development.

The criteria for the predominantly hyperactive/impulsive presentation of ADHD include six or more symptoms of hyperactivity and impulsivity. These symptoms may include excessive talking, difficulty staying seated, and impulsive decision-making. As with the predominantly inattentive presentation, the symptoms must interfere with the individual’s functioning or development.

The most common subtype is the combined presentation, which requires the presence of symptoms from both the inattentive and hyperactive/impulsive categories. This subtype is characterized by symptoms such as frequent interrupting, difficulty waiting for a turn, and disorganization.

The neurobiological and etiological factors contributing to ADHD are complex and not fully understood. Research suggests an interplay between genetic, environmental, and neurological factors. Multiple genes associated with the neurotransmitter systems, particularly dopamine, have been implicated in ADHD. Dysfunction in the prefrontal cortex, responsible for executive functions such as attention and impulse control, is also observed in individuals with ADHD. Additionally, prenatal and perinatal risk factors, such as maternal smoking and exposure to toxins, may increase the risk of developing ADHD.

Atomoxetine is a nonstimulant medication used in the treatment of ADHD. It functions as a selective norepinephrine reuptake inhibitor. By increasing the amount of norepinephrine in the brain, it helps regulate attention and impulse control. Unlike stimulant medications, atomoxetine does not have the potential for abuse or addiction.

It is important to note that the use of atomoxetine may be associated with some side effects. The most common side effects include gastrointestinal symptoms such as nausea, vomiting, and decreased appetite. Other potential side effects may include increased heart rate and blood pressure, dizziness, and mood changes. Atomoxetine may also lead to changes in liver enzymes, although this is rare. As with any medication, it is crucial to monitor patients for any adverse reactions or changes in symptoms.

When considering atomoxetine as a treatment option, several factors should be taken into account. Firstly, a comprehensive evaluation of the patient’s medical history is necessary, as certain medical conditions may pose a contraindication to atomoxetine use. For example, individuals with narrow-angle glaucoma, severe cardiovascular disease, or significant liver impairment should not take this medication.

Furthermore, it is essential to consider potential drug interactions, as atomoxetine may interact with other medications metabolized by the liver’s cytochrome P450 system. These interactions can affect the levels of other medications in the body and increase the risk of adverse effects. Therefore, a thorough review of the patient’s medication profile is essential to avoid potential drug interactions.

In conclusion, ADHD is a complex psychiatric disorder with a set of standardized diagnostic criteria outlined in the DSM-5. The neurobiological and etiological factors contributing to ADHD involve an interplay between genetic, environmental, and neurological factors. Atomoxetine, a nonstimulant medication, is commonly used as a treatment for ADHD. It acts as a selective norepinephrine reuptake inhibitor, helping regulate attention and impulse control. However, atomoxetine may have side effects, and considerations such as medical history, contraindications, and drug interactions should be carefully evaluated before prescribing it to a patient.

Do you need us to help you on this or any other assignment?


Make an Order Now